Evidence map›Paper›PMID 40316817›Full record

ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2026

Education Is Treatment: Integrating Chemosensory Dysfunction Education in Oncology Care.

Kara Stromberg, Valentina Parma, Kristen Manley, Dylan Sherry, Michael J Hall, Alissa A Nolden

Abstract read
In one paragraph

Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kara Stromberg *Fox Chase Cancer Center, Philadelphia, PA, USA.
Valentina Parma *Monell Chemical Senses Center, Philadelphia, PA, USA.
Kristen ManleyFox Chase Cancer Center, Philadelphia, PA, USA.
Dylan SherryFox Chase Cancer Center, Philadelphia, PA, USA.
Michael J HallFox Chase Cancer Center, Philadelphia, PA, USA.
Alissa A NoldenDepartment of Food Science, University of Massachusetts Amherst, Amherst, MA, USA. anolden@umass.edu.ORCID http://orcid.org/0000-0001-9525-5580

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemosensory dysfunction, defined as an altered or lost taste and smell, is a prevalent side effect of cancer treatment, with 93% of patients complaining of taste and 60% complaining of changes in smell. Despite their impact, it is an underrecognized symptom, impairing nutritional intake, quality of life, and treatment outcomes. Surprisingly, taste and smell changes are rarely assessed or addressed in oncology care. This commentary highlights the educational gap faced by clinicians and reports the results of a pilot educational intervention consisting of a 15-min podcast. The results indicate significant improvements in provider knowledge and confidence to support patients experiencing chemosensory dysfunction. By embedding chemosensory education into nutrition, survivorship, and interprofessional care pathways, clinicians can better recognize, document, and respond to these symptoms. Reframing taste and smell not as minor nuisances but as critical facets of patient well-being represents a shift toward more comprehensive oncology care.

Indexed as

Medical OncologyNeoplasmsOlfaction DisordersTaste DisordersHumansQuality of LifeAnosmiaCancerClinician educationDysgeusiaEducation interventionSmell lossTaste loss

Identifiers

PMID40316817
PMCPMC13222202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.